ImmunityBio to serve as sole U.S. Biologics License Application applicant for the Tokyo strain of BCG and plans to engage with U.S. Food and Drug Administration (FDA) on regulatory pathway to address ...
Chan of Marin Health UCSF Health Clinic, in collaboration with Dr. Kymora Scotland and colleagues from UCLA, presented a ...
David Matheson discusses the patient perspective on radiographic progression-free survival as a clinical trial endpoint. Dr. Matheson argues that imaging-based progression is more ...
Tyler Seibert outlines his approach to radiation therapy for the primary tumor in metastatic hormone-sensitive prostate cancer. He summarizes three randomized trials that consiste ...
Also previously reported, there was no benefit for extended pelvic lymphadenectomy in the overall cohort for metastasis free ...
Discussion on the Use of Bone Modifying Agents in Metastatic Prostate Cancer - Tian Zhang and Evan Yu Discussion on Patient Selection for Radioligand Therapy in Prostate Cancer - Oliver Sartor and ...
Alicia Morgans: I am going to be talking about incorporating PSMA PETs into registration trials with an example of a study that is relying on a PSMA PET endpoint as the primary endpoint in the study.
The Role of Multimodality Imaging in Selection, Response Assessment, and Follow-up of Patients Receiving 177Lutetium-PSMA-Therapy - Beyond the Abstract ...
(UroToday.com) The 2025 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting held in New Orleans, LA, was host to a session on non-beta emitter PSMA radioligand therapy. Dr. David ...
Thulium Fiber Laser Versus Holmium MOSES™ Laser Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia: A Randomized Prospective Clinical Study - Beyond the Abstract ...
Johnson & Johnson’s INLEXZO™ (Gemcitabine Intravesical System) Delivers 74 Percent Disease-Free Survival at One Year in BCG-Unresponsive, High-Risk, Papillary-Only NMIBC New Cretostimogene ...
AUA 2026 Bladder Cancer Presentations: EG70, POTOMAC, and En-bloc Resection - Patrick Hensley AUA 2026 Preview: Perioperative EV/Pembro, ctDNA, and Bladder Preservation - Petros Grivas AUA 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results